Patients' Access to Treatments Act of 2017
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Patients' Access to Treatments Act of 2017
This bill amends the Public Health Service Act to establish cost sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost sharing structure. Such health plans may not impose higher cost sharing requirements, including copayment and coinsurance, for specialty drugs than for other prescription drugs in a nonpreferred brand name drug tier. If a health plan's formulary contains more than one nonpreferred brand name drug tier, the tier with the lowest cost sharing applies.
Referred to the Subcommittee on Health.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 2999: Patients' Access to Treatments Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-HR-2999/
"H.R. 2999: Patients' Access to Treatments Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-2999/.
H.R. 2999, 115th Cong. (2026), https://openamerica.io/bill/115-HR-2999/.
[H.R. 2999: Patients' Access to Treatments Act of 2017](https://openamerica.io/bill/115-HR-2999/)